Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cancer agent comprising HVJ-E and CXCL2

Anti-cancer agent comprising HVJ-E and CXCL2

US Patent 10441613 · Granted Oct 15, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Light irradiation device2022
Method for collecting functional cells in vivo with high efficiency2021
Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal s2021
Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor2021
Anticancer agent comprising HVJ-E and immune checkpoint protein inhibitor2021
Micro-channel device and method for manufacturing micro-channel device2021
Production system2021
Light irradiation device and light irradiation method2020
Double container2020
Light irradiation device2019
Production system2019
Gearbox and method for assembling same2018